{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:57:02Z","timestamp":1760151422122,"version":"build-2065373602"},"reference-count":18,"publisher":"Georg Thieme Verlag KG","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1055\/a-2532-6320","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:37:12Z","timestamp":1760135832000},"page":"1283-1292","source":"Crossref","is-referenced-by-count":0,"title":["Screening und Pr\u00e4vention der chronischen Virushepatitis"],"prefix":"10.1055","volume":"150","author":[{"given":"Markus","family":"Cornberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Sandmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,10,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1055\/a-1498-2512","article-title":"S3-Leitlinie der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion. AWMF-Register-Nr. 021\u201311","volume":"59","author":"M Cornberg","year":"2021","journal-title":"Z Gastroenterol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1055\/a-1226-0241","article-title":"Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-Infektion","volume":"58","author":"C Sarrazin","year":"2020","journal-title":"Z Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2025.03.018","article-title":"EASL Clinical Practice Guidelines on the management of hepatitis B virus infection","author":"European Association for the Study of the Liver","year":"2025","journal-title":"J Hepatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2023.05.001","article-title":"EASL Clinical Practice Guidelines on hepatitis delta virus","volume":"79","author":"European Association for the Study of the Liver","year":"2023","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.jhep.2018.03.005","article-title":"Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver: EASL Clinical Practice Guidelines on hepatitis E virus infection","volume":"68","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101122","article-title":"Successful hepatitis B and C screening in the health check-up in the German primary care setting","volume":"6","author":"O B\u00e4tz","year":"2024","journal-title":"JHEP Rep"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1016\/j.jhep.2015.01.011","article-title":"Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios","volume":"62","author":"I Wolffram","year":"2015","journal-title":"J Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","article-title":"Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study","volume":"8","author":"Polaris Observatory Collaborators","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1055\/a-2435-5069","article-title":"Significant increase in newly diagnosed hepatitis B and C cases in Germany due to screening","volume":"63","author":"D H\u00fcppe","year":"2025","journal-title":"Z Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.10.034","article-title":"Population-based screening works: Effect of integrating screening for hepatitis B and C into the general health check-up in Germany","author":"D H\u00fcppe","year":"2023","journal-title":"J Hepatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/a-1777-6112","article-title":"A Global Systematic Review of Hepatitis C Elimination Efforts through Micro-Elimination","volume":"42","author":"JV Lazarus","year":"2022","journal-title":"Semin Liver Dis"},{"issue":"02","key":"ref14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/liv.15446","article-title":"Securing Wider EU Commitment to the Elimination of HCV","volume":"43","author":"H Wedemeyer","year":"2023","journal-title":"Liver Int"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.cgh.2018.08.080","article-title":"Cost Effectiveness of Universal Screening for Hepatitis C Virus Infection in the Era of Direct-Acting, Pangenotypic Treatment Regimens","volume":"17","author":"MH Eckman","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/apt.18424","article-title":"Successful Amendment of an Existing Hepatitis B Screening Programme by a Guideline Recommended Hepatitis D Screening in the Primary Care Setting","volume":"61","author":"T Herta","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/add.16147","article-title":"Comprehensive needle and syringe program and opioid agonist therapy reduce HIV and hepatitis c virus acquisition among people who inject drugs in different settings: A pooled analysis of emulated trials","volume":"118","author":"DK Santen","year":"2023","journal-title":"Addiction"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S2468-1253(24)00442-4","article-title":"Global, regional, and national estimates of hepatitis C virus (HCV) infection incidence among people who inject drugs and number of new annual HCV infections attributable to injecting drug use: a multi-stage analysis","volume":"10","author":"A Artenie","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/cid\/cix1007","article-title":"Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy","volume":"66","author":"A Boerekamps","year":"2018","journal-title":"Clin Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/HEP.0000000000000958","article-title":"Early treatment of acute or recently acquired hepatitis C: An important tool on the path to HCV elimination!","volume":"81","author":"M Cornberg","year":"2025","journal-title":"Hepatology"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2532-6320.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:37:22Z","timestamp":1760135842000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2532-6320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":18,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,10,10]]},"published-print":{"date-parts":[[2025,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2532-6320","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}